2650 related articles for article (PubMed ID: 20952254)
41. Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.
Berois N; De Cremoux P; Mazal D; Sica A; Cedeira M; Caserta B; Barrios E; Osinaga E; Sastre-Garau X
Int J Gynecol Cancer; 2013 Mar; 23(3):527-32. PubMed ID: 23392403
[TBL] [Abstract][Full Text] [Related]
42. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR).
Yamakawa Y; Forslund O; Teshima H; Hasumi K; Kitagawa T; Hansson BG
Gynecol Oncol; 1994 May; 53(2):190-5. PubMed ID: 8188078
[TBL] [Abstract][Full Text] [Related]
44. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
[TBL] [Abstract][Full Text] [Related]
45. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines.
Cuschieri K; Brewster DH; Williams AR; Millan D; Murray G; Nicoll S; Imrie J; Hardie A; Graham C; Cubie HA
Br J Cancer; 2010 Mar; 102(5):930-2. PubMed ID: 20145611
[TBL] [Abstract][Full Text] [Related]
46. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
47. Genotyping of human papillomavirus in paraffin embedded cervical tissue samples from women in Ethiopia and the Sudan.
Abate E; Aseffa A; El-Tayeb M; El-Hassan I; Yamuah L; Mihret W; Bekele L; Ashenafi S; El-Dawi N; Belayneh M; El-Hassan A; Engers H
J Med Virol; 2013 Feb; 85(2):282-7. PubMed ID: 23160919
[TBL] [Abstract][Full Text] [Related]
48. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
[TBL] [Abstract][Full Text] [Related]
49. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.
Andersson S; Rylander E; Larson B; Sigurdardottir S; Backlund I; Sällström J; Wilander E
Oncol Rep; 2003; 10(1):175-9. PubMed ID: 12469166
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
Pista A; de Oliveira CF; Lopes C; Cunha MJ;
Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
[TBL] [Abstract][Full Text] [Related]
51. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
[TBL] [Abstract][Full Text] [Related]
52. The Variable Characteristics of Human Papillomavirus in Squamous Cell Carcinoma and Adenocarcinoma of Cervix in China.
Chen W; Sun H; Molijn A; Zeng L; Kang L; Jenkins D; Zhang S; Cui J; Wu Z; Pirog E; Shen G; Zhang X; Qiao Y;
J Low Genit Tract Dis; 2018 Oct; 22(4):355-361. PubMed ID: 30074955
[TBL] [Abstract][Full Text] [Related]
53. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of human papillomavirus genotypes in women with cervical cancer in Papua New Guinea.
Tabone T; Garland SM; Mola G; O'Connor M; Danielewski J; Tabrizi SN
Int J Gynaecol Obstet; 2012 Apr; 117(1):30-2. PubMed ID: 22325971
[TBL] [Abstract][Full Text] [Related]
55. High prevalence of multiple human papillomavirus infection in Japanese patients with invasive uterine cervical cancer.
Watari H; Michimata R; Yasuda M; Ishizu A; Tomaru U; Xiong Y; Hassan MK; Sakuragi N
Pathobiology; 2011; 78(4):220-6. PubMed ID: 21778789
[TBL] [Abstract][Full Text] [Related]
56. Secular trends of HPV genotypes in invasive cervical cancer in Cali, Colombia 1950-1999.
Sanchez GI; Bravo LE; Hernandez-Suarez G; Tous S; Alemany L; de Sanjose S; Bosch FX; Muñoz N
Cancer Epidemiol; 2016 Feb; 40():173-8. PubMed ID: 26771314
[TBL] [Abstract][Full Text] [Related]
57. HPV genotyping in adenocarcinoma of the uterine cervix in Thailand.
Siriaunkgul S; Utaipat U; Suthipintawong C; Tungsinmunkong K; Triratanachat S; Khunamornpong S
Int J Gynaecol Obstet; 2013 Dec; 123(3):226-30. PubMed ID: 24095305
[TBL] [Abstract][Full Text] [Related]
58. Against which human papillomavirus types shall we vaccinate and screen? The international perspective.
Muñoz N; Bosch FX; Castellsagué X; Díaz M; de Sanjose S; Hammouda D; Shah KV; Meijer CJ
Int J Cancer; 2004 Aug; 111(2):278-85. PubMed ID: 15197783
[TBL] [Abstract][Full Text] [Related]
59. HPV genotyping from invasive cervical cancer in Chile.
Roa JC; Garcia P; Gomez J; Fernández W; Gaete F; Espinoza A; Lepetic A; Suarez E
Int J Gynaecol Obstet; 2009 May; 105(2):150-3. PubMed ID: 19249046
[TBL] [Abstract][Full Text] [Related]
60. Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors.
Hammouda D; Muñoz N; Herrero R; Arslan A; Bouhadef A; Oublil M; Djedeat B; Fontanière B; Snijders P; Meijer C; Franceschi S
Int J Cancer; 2005 Jan; 113(3):483-9. PubMed ID: 15455386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
